Share on StockTwits

Exactech (NASDAQ:EXAC) CFO Joel C. Phillips sold 5,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $23.21, for a total transaction of $116,050.00. Following the completion of the sale, the chief financial officer now directly owns 89,287 shares of the company’s stock, valued at approximately $2,072,351. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Exactech (NASDAQ:EXAC) traded up 2.89% on Monday, hitting $25.29. The stock had a trading volume of 40,150 shares. Exactech has a 52-week low of $18.01 and a 52-week high of $25.14. The stock has a 50-day moving average of $22.42 and a 200-day moving average of $23.16. The company has a market cap of $345.4 million and a price-to-earnings ratio of 21.75.

Exactech (NASDAQ:EXAC) last released its earnings data on Monday, April 21st. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.29 by $0.01. The company had revenue of $63.30 million for the quarter, compared to the consensus estimate of $63.05 million. During the same quarter in the prior year, the company posted $0.29 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. On average, analysts predict that Exactech will post $1.21 earnings per share for the current fiscal year.

Exactech, Inc develops, manufactures and sells orthopedic implant devices, related surgical instruments and biological material and services to make patients more mobile.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.